Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical data support the development of immunotherapeutic strategies for AD

July 27, 2004

Therapeutic benefits found with rosiglitazone in patients with early AD

July 27, 2004

Update on the safety and pharmacokinetics of SRA-333

July 27, 2004

Isis scientists describe new anti-HCV agents targeting IRES

July 27, 2004

Novel protein kinase inhibitors and their use in cancer therapy

July 27, 2004

Novel cannabinoid CB2 agonists under study at Sanofi-Synthelabo

July 27, 2004

Actelion claims new sulfamide-based endothelin antagonists

July 27, 2004

Novel tachykinin NK3 antagonists with potential in CNS conditions

July 27, 2004

New beta-secretase inhibitors prepared and tested at GSK

July 27, 2004

Incyte researchers present novel chemokine CCR2/CCR5 antagonists

July 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...